These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10101607)

  • 1. [Function and therapeutic potential of the dopamine D3 receptor].
    Sokoloff P; Diaz J; Bordet R; Griffon N; Perachon S; Pilon C; Ridray S; Schwartz JC
    C R Seances Soc Biol Fil; 1998; 192(6):1111-25. PubMed ID: 10101607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence.
    Schwartz JC; Diaz J; Bordet R; Griffon N; Perachon S; Pilon C; Ridray S; Sokoloff P
    Brain Res Brain Res Rev; 1998 May; 26(2-3):236-42. PubMed ID: 9651537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja.
    Gurevich EV; Himes JW; Joyce JN
    J Pharmacol Exp Ther; 1999 Apr; 289(1):587-98. PubMed ID: 10087054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
    Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
    Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
    Lammers CH; Diaz J; Schwartz JC; Sokoloff P
    Mol Psychiatry; 2000 Jul; 5(4):378-88. PubMed ID: 10889548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain.
    Tremblay M; Rouillard C; Lévesque D
    Synapse; 1999 Apr; 32(1):51-7. PubMed ID: 10188638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional role of dopamine D3 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):3-11. PubMed ID: 15027325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
    Guillin O; Diaz J; Carroll P; Griffon N; Schwartz JC; Sokoloff P
    Nature; 2001 May; 411(6833):86-9. PubMed ID: 11333982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
    Robertson GS; Lee CJ; Sridhar K; Nakabeppu Y; Cheng M; Wang YM; Caron MG
    Eur J Neurosci; 2004 Dec; 20(11):3189-94. PubMed ID: 15579174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in dopamine D3 receptors in the circling (ci3) rat mutant.
    Schirmer M; Nobrega JN; Harrison SJ; Löscher W
    Neuroscience; 2007 Feb; 144(4):1462-9. PubMed ID: 17187934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
    Le Foll B; Diaz J; Sokoloff P
    Synapse; 2003 Mar; 47(3):176-83. PubMed ID: 12494400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation.
    Karasinska JM; George SR; Cheng R; O'Dowd BF
    Eur J Neurosci; 2005 Oct; 22(7):1741-50. PubMed ID: 16197514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors.
    Zhang J; Xu M
    Ann N Y Acad Sci; 2006 Aug; 1074():1-12. PubMed ID: 17105899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca²⁺ dependent manner.
    Avalos-Fuentes A; Loya-López S; Flores-Pérez A; Recillas-Morales S; Cortés H; Paz-Bermúdez F; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2013 Aug; 71():273-81. PubMed ID: 23602989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
    St-Hilaire M; Landry E; Lévesque D; Rouillard C
    Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
    Le Foll B; Diaz J; Sokoloff P
    Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.
    Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S
    Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.